Product Information
ARIPIPRAZOLE ODT 10 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $2.4701 per EA under NDC 62332010330. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Apr 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332010330
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202102FDA Approved
4/28/2015
TE Code
AB
On Market Since
7/7/2016
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE ODT 10 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 78.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4701 per EA |
|---|---|
| All-time high | $11.5188 (May 15, 2024) |
| All-time low | $2.1876 (Aug 21, 2024) |
| 52-week high | $3.5110 |
| 52-week low | $2.4191 |
| Median price | $3.0539 |
| Average price | $3.6394 |
| Largest weekly change | -60.3% (Jul 17, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE ODT 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE ODT 10 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $2.4701 per EA (NDC 62332010330), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE ODT 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE ODT 10 MG TABLET has declined 78.6%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE ODT 10 MG TABLET?
Since Apr 17, 2024, the NADAC for ARIPIPRAZOLE ODT 10 MG TABLET has ranged from a low of $2.1876 (Aug 21, 2024) to a high of $11.5188 (May 15, 2024), with a median of $3.0539 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE ODT 10 MG TABLET?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARIPIPRAZOLE 10 MG TABLET, is $0.1117 per EA — about 95% below ARIPIPRAZOLE ODT 10 MG TABLET.
Who manufactures ARIPIPRAZOLE ODT 10 MG TABLET?
ARIPIPRAZOLE ODT 10 MG TABLET (NDC 62332010330) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.